Said SM, Visscher DW, Nassar A, et al. Flat epithelial atypia and risk of breast cancer: a Mayo cohort study. Cancer. 2015;121(10):1548–55. https://doi.org/10.1002/cncr.29243.
Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In: Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon, France, 2003;63–73.
Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307–17. https://doi.org/10.1002/path.2808.
Article CAS PubMed Google Scholar
Aroner SA, Collins LC, Schnitt SJ, et al. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010;12(4):R61. https://doi.org/10.1186/bcr2624.
Article PubMed PubMed Central Google Scholar
Rudin AV, Hoskin TL, Fahy A, et al. Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2017;24(12):3549–58. https://doi.org/10.1245/s10434-017-6059-0.
Falomo E, Adejumo C, Carson KA, et al. Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at US academic institutions. Curr Probl Diagn Radiol. 2019;48(5):462–6. https://doi.org/10.1067/j.cpradiol.2018.06.004.
Nakhlis F, Gilmore L, Gelman R, et al. Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol. 2016;23(3):722–8. https://doi.org/10.1245/s10434-015-4922-4.
Becker AK, Gordon PB, Harrison DA, et al. Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: is excisional biopsy indicated? AJR Am J Roentgenol. 2013;200(3):682–8. https://doi.org/10.2214/AJR.11.8090.
Khoumais NA, Scaranelo AM, Moshonov H, et al. Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast. Ann Surg Oncol. 2013;20(1):133–8. https://doi.org/10.1245/s10434-012-2591-0.
Dialani V, Venkataraman S, Frieling G, Schnitt SJ, Mehta TS. Does isolated flat epithelial atypia on vacuum-assisted breast core biopsy require surgical excision? Breast J. 2014;20(6):606–14. https://doi.org/10.1111/tbj.12332.
Chan PMY, Chotai N, Lai ES, et al. Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision. Breast. 2018;37:13–7. https://doi.org/10.1016/j.breast.2017.10.005.
Ouldamer L, Poisson E, Arbion F, et al. All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision. Breast. 2018;40:4–9. https://doi.org/10.1016/j.breast.2018.03.012.
Liu C, Dingee CK, Warburton R, et al. Pure flat epithelial atypia identified on core needle biopsy does not require excision. Eur J Surg Oncol. 2020;46(2):235–9. https://doi.org/10.1016/j.ejso.2019.10.029.
Gordon PB, Branch E. Upgrade rate of flat epithelial atypia diagnosed at stereotactic core needle biopsy of microcalcifications: is excisional biopsy indicated? J Breast Imaging. 2020;2(4):336–42. https://doi.org/10.1093/jbi/wbaa037.
Grabenstetter A, Brennan S, Salagean ED, Morrow M, Brogi E. Flat epithelial atypia in breast core needle biopsies with radiologic-pathologic concordance: is excision necessary? Am J Surg Pathol. 2020;44(2):182–90. https://doi.org/10.1097/PAS.0000000000001385.
Article PubMed PubMed Central Google Scholar
Miller-Ocuin JL, Fowler BB, Coldren DL, et al. Is excisional biopsy needed for pure FEA diagnosed on a core biopsy? Am Surg. 2020;86(9):1088–90. https://doi.org/10.1177/0003134820943546.
Srour MK, Donovan C, Chung A, et al. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy. Breast J. 2020;26(4):679–84. https://doi.org/10.1111/tbj.13507.
Lamb LR, Bahl M, Gadd MA, Lehman CD. Flat epithelial atypia: upgrade rates and risk-stratification approach to support informed decision making. J Am Coll Surg. 2017;225(6):696–701. https://doi.org/10.1016/j.jamcollsurg.2017.08.022.
Ferre R, Kuzmiak CM. Upgrade rate of percutaneously diagnosed pure flat epithelial atypia: systematic review and meta-analysis of 1924 lesions. J Osteopath Med. 2022;122(5):253–62. https://doi.org/10.1515/jom-2021-0206.
DiPasquale A, Silverman S, Farag E, Peiris L. Flat epithelial atypia: are we being too aggressive? Breast Cancer Res Treat. 2020;179(2):511–7. https://doi.org/10.1007/s10549-019-05481-9.
O’Malley FP, Mohsin SK, Badve S, et al. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006;19(2):172–9. https://doi.org/10.1038/modpathol.3800514.
Gomes DS, Porto SS, Balabram D, Gobbi H. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Diagn Pathol. 2014;9:121. https://doi.org/10.1186/1746-1596-9-121.
Article PubMed PubMed Central Google Scholar
Kim WG, Cummings MC, Lakhani SR. Pitfalls and controversies in pathology impacting breast cancer management. Expert Rev Anticancer Ther. 2020;20(3):205–19. https://doi.org/10.1080/14737140.2020.1738222.
Article CAS PubMed Google Scholar
Laws A, Katlin F, Nakhlis F, et al. Atypical lobular hyperplasia and classic lobular carcinoma in situ can be safely managed without surgical excision. Ann Surg Oncol. 2022;29(3):1660–7. https://doi.org/10.1245/s10434-021-10827-z.
Matar R, Sevilimedu V, Park A, King TA, Pilewskie M. Comparison of outcomes for classic-type lobular carcinoma in situ managed with surgical excision after core biopsy versus observation. Ann Surg Oncol. 2022;29(3):1670–9. https://doi.org/10.1245/s10434-021-10828-y.
Cuzick J. Preventive therapy for cancer. Lancet Oncol. 2017;18(8):e472–82. https://doi.org/10.1016/S1470-2045(17)30536-3.
Gao Y, Albert M, Young Lin LL, et al. What happens after a diagnosis of high-risk breast lesion at stereotactic vacuum-assisted biopsy? An observational study of postdiagnosis management and imaging adherence. Radiology. 2018;287(2):423–31. https://doi.org/10.1148/radiol.2017171665.
Flanagan MR, Zabor EC, Stempel M, et al. Chemoprevention uptake for breast cancer risk reduction varies by risk factor. Ann Surg Oncol. 2019;26(7):2127–35. https://doi.org/10.1245/s10434-019-07236-8.
Article PubMed PubMed Central Google Scholar
Bychkovsky B, Laws A, Katlin F, et al. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat. 2022;193(2):417–27. https://doi.org/10.1007/s10549-022-06577-5.
留言 (0)